Literature DB >> 29569462

Conceptualizing Obesity as a Chronic Disease: An Interview With Dr. Arya Sharma.

Arya M Sharma1, Donna L Goodwin1, Janice Causgrove Dunn1.   

Abstract

Dr. Arya M. Sharma challenges the conventional wisdom of relying simply on "lifestyle" approaches involving exercise, diet, and behavioral interventions for managing obesity, suggesting that people living with obesity should receive comprehensive medical interventions similar to the approach taken for other chronic diseases such as Type 2 diabetes or hypertension. He purports that the stigma-inducing focus on self-failing (e.g., coping through food, laziness, lack of self-regulation) does not address biological processes that make obesity a lifelong problem for which there is no easy solution. Interdisciplinary approaches to obesity are advocated, including that of adapted physical activity. Physical activity has multifaceted impacts beyond increasing caloric expenditure, including improved sleep, better mood, increased energy levels, enhanced self-esteem, reduced stress, and an enhanced sense of well-being. The interview with Dr. Sharma, transcribed from a keynote address delivered at the North American Adapted Physical Activity Symposium on September 22, 2016, in Edmonton, AB, Canada, outlines his rationale for approaching obesity as a chronic disease.

Entities:  

Keywords:  disability models; interdisciplinary approaches; medical conditions; obesity treatment and management

Mesh:

Year:  2018        PMID: 29569462     DOI: 10.1123/apaq.2017-0193

Source DB:  PubMed          Journal:  Adapt Phys Activ Q        ISSN: 0736-5829            Impact factor:   2.929


  2 in total

1.  Weight Stigma and Disease and Disability Concepts of Obesity: A Survey of the German Population.

Authors:  Anja Hilbert; Markus Zenger; Claudia Luck-Sikorski; Elmar Brähler
Journal:  Obes Facts       Date:  2021-08-30       Impact factor: 3.942

Review 2.  Obesity: global epidemiology and pathogenesis.

Authors:  Matthias Blüher
Journal:  Nat Rev Endocrinol       Date:  2019-05       Impact factor: 43.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.